機構典藏系統110年3月發表論文 NEW! 2021 年 4 月 13 日 NHRILIB 最新消息 A highly selective and potent CXCR4 antagonist for hepatocellular carcinoma treatment.(IF 2019:9.412)New design to remove leukocytes from platelet-rich plasma (PRP) based on cell dimension rather than density.(IF 2019:8.724)c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation.(IF 2019:8.579)Targeting lysosomal cysteine protease cathepsin S reveals immunomodulatory therapeutic strategy for oxaliplatin-induced peripheral neuropathy.(IF 2019:8.579)Genome-wide CRISPR/Cas9 knockout screening uncovers a novel inflammatory pathway critical for resistance to arginine-deprivation therapy.(IF 2019:8.579)
